Adverse event | Treatment phase | AE grade | Note |
---|---|---|---|
Infections and infestations | |||
Sepsis | Consolidation | 4 | Citrobacter |
Invasive fungal infections | None | N/A | |
Blood and lymphatic system disorders | |||
Febrile neutropenia | Induction, consolidation, re-induction | 3 | |
Anemia | Induction, consolidation, re-induction | 3 | |
Platelet count decreased | Induction, consolidation, re-induction | 3–4 | |
Coagulation disorders (fibrinogen decreased) | Induction, consolidation, re-induction | 2–3 | |
Gastrointestinal disorders | |||
Mucositis | Induction, consolidation | 3 | |
Pancreatitis | None | N/A | |
Hepatobiliary disorders | |||
Transaminitis (ALT, AST increased) | Consolidation, re-induction | 3 | |
Blood bilirubin increased | Early intensification | 2 | |
GGT increased | Early intensification, consolidation, re-induction | 3 3–4 | |
Metabolism and nutrition disorders | |||
Hyperglycemia | Induction, consolidation, re-induction | 3 | Steroid-induced |
Anorexia (malnutrition) | Induction, consolidation | 2–3 | Clinically grade 2, laboratory and neuroradiology results indicate a higher grade |
Iron overload | Re-induction | 2 | |
Endocrine disorders | |||
Adrenal insufficiency | Induction, consolidation, re-induction | 2–3 | |
Hypothyroidism | Induction | 2 | |
Vascular disorders | |||
Hypertension | Induction, ongoing | 3 | |
Thromboembolic events | None | N/A | |
Renal and urinary disorders | |||
Chronic kidney disease | Consolidation | 2 | Underlying condition |
Acute kidney disease | Early intensification | 3 | Amfotericin B-induced |
Nervous system disorders | |||
Polineuropathy | Induction, ongoing | 3 | |
Convulsions | Re-induction | 2 | |
Psychiatric disorders | |||
Psychosis | Re-induction | 3–4 | Steroid-induced |
Immune system disorders | |||
Allergic reactions | None | N/A | |
Musculoskeletal and connective tissue disorders | |||
Avascular necrosis | None | N/A | |
Osteoporosis | Re-induction | 2 | |
Skin and subcutaneous tissue disorders | |||
Dermatitis | Re-induction | 2–3 | Steroid-induced |